Product development

Pre‑formulation is the scientific evaluation of an active pharmaceutical ingredient to define its physicochemical properties and formulation constraints. At Groupe PARIMA, pre‑formulation studies generate data on solubility, stability, excipient compatibility, and critical attributes to guide formulation design and development strategy from the earliest stages.

Formulation development involves designing a drug product composition that delivers consistent performance, stability, and scalability. Groupe PARIMA develops small molecule non‑sterile formulations by aligning excipient selection, process parameters, and target product characteristics to establish robust, reproducible process ready for scale‑up.

Process scale‑up translates laboratory or pilot‑scale batches into manufacturing‑scale product while maintaining quality and process control. At Groupe PARIMA, scale‑up activities are driven by a defined understanding of formulation behavior and critical process parameters to ensure consistency across development and manufacturing scales.

Technology transfer is the structured transfer of product, process, and analytical knowledge from development to manufacturing. Groupe PARIMA manages technology transfer through comprehensive documentation, defined control strategies, and cross‑functional collaboration to ensure accurate and controlled execution at manufacturing scale.

Process validation demonstrates that a manufacturing process operates consistently and reproducibly within defined parameters. At Groupe PARIMA, process validation builds directly on development data, critical process parameters, and defined quality attributes to support regulatory requirements and commercial readiness.